Bio Rad Laboratories Inc (NYSE:BIO)

523.09
Delayed Data
As of Aug 07
 -2.13 / -0.41%
Today’s Change
309.38
Today|||52-Week Range
540.06
+41.36%
Year-to-Date
Bio-Rad Laboratories Inc (BIO) (BIO.B) Q2 2020 Earnings Call Transcript
Jul 31 / MotleyFool.com - Paid Partner Content
Bio-Rad Labs Q2 2020 Earnings Preview
Jul 29 / Seeking Alpha - Paid Partner Content
Bio-Rad Labs EPS beats by $0.46, beats on revenue
Jul 30 / Seeking Alpha - Paid Partner Content
Notable earnings after Thursday's close
Jul 29 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close525.22
Today’s open522.80
Day’s range518.51 - 527.00
Volume181,442
Average volume (3 months)269,859
Market cap$12.9B
Data as of 4:00pm ET, 08/07/2020

Growth & Valuation

Earnings growth (last year)+380.91%
Earnings growth (this year)+9.75%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+0.97%
P/E ratio8.1
Price/Sales4.83
Price/Book2.73

Competitors

 Today’s
change
Today’s
% change
WATWaters Corp+1.66+0.79%
PKIPerkinElmer Inc+0.27+0.23%
QGENQiagen NV+0.43+0.92%
BRKRBruker Corp+0.65+1.49%
Data as of 4:00pm ET, 08/07/2020

Financials

Next reporting dateOctober 29, 2020
EPS forecast (this quarter)$1.80
Annual revenue (last year)$2.3B
Annual profit (last year)$1.8B
Net profit margin76.08%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Hercules, California

Forecasts